Mid-Atlantic Bio

Twenty-six Companies from across the Mid-Atlantic Region Represent Biotech, Biopharmaceutical Drug Development and Discovery, Devices and Vaccine Sectors

Chantilly, Va. — Ten later-stage growth companies and 16 emerging companies will present before an audience of venture capitalists and industry professionals at 2008 Mid-Atlantic Bio on October 23 and 24 at the Westfields Marriott Washington Dulles in Chantilly, Va. Dedicated to promoting the biotechnology industry in the Mid-Atlantic region, the conference is hosted collectively by the region’s most influential bioscience and investor associations, the Mid-Atlantic Venture Association (MAVA), the Tech Council of Maryland/MdBio (MdBio) and the Virginia Biotechnology Association (VaBIO).

Each year at Mid-Atlantic Bio, a limited number of life science companies are invited to present before an audience of capital sources, including venture capitalists, angel investors, and various other qualified financing sources, along with life sciences industry attendees. This year three distinct tracks will be featured: Showcase (later-stage growth companies), Growth Watch (emerging companies), and International (visiting delegations from foreign-based companies).

“With the various tracks this year, we continue our efforts to build a broad platform that encourages investor interest, innovation review and industry collaboration,” stated Julia Spicer, Executive Director of MAVA and Host Committee member. “The more mature showcase and interesting emerging technology companies are outstanding representatives of a growing, vibrant community of companies doing business in the Mid-Atlantic region,” she added.

Presenting companies were chosen through an industry review process with input from more than 25 investment institutions and industry professionals.

Showcase Track: The later stage companies chosen to present in Showcase Track include:

• Alba Therapeutics, Baltimore, Md.
• Amplimmune, Inc., Rockville, Md.
• Arcion Therapeutics, Baltimore, Md.
• Avid Radiopharmaceuticals, Philadelphia, Pa.
• BioSET, Rockville, Md.
• MacroGenics, Rockville, Md.
• PixelOptics, Roanoke, Va.
• Supernus Pharmaceuticals, Rockville, Md.
• Tranzyme, Durham, N.C.
• With more to follow

Emerging Growth: The emerging companies chosen to present in the Growth Watch Track include:

• Aparna Biosciences Corp., Rockville, Md.
• Arginetix, Inc., Lutherville, Md.
• BioMarker Strategies, Baltimore, Md.
• Calibrant Biosystems, Inc., Gaithersburg, Md.
• Ceres Nanosciences, LLLP, Herndon, Va.
• Chikujee Therapeutics, Germantown, Md.
• Gliknik Inc., Baltimore, Md.
• HemoSonics, Charlottesville, Va.
• I3 Oncology, LLC, Laurel, Md.
• Innovative Biologics, Herndon, Va.
• Keraderm, LLC, Blacksburg, Va.
• Midwest Proteomics Inc., Richmond, Va.
• Neuronascent, Inc., Clarksville, Md.
• OTraces, Herndon, Va.
• Phase Bioscience, Inc., Morrisville, N.C.
• Provid Pharmaceuticals Inc., North Brunswick, N.J.

International: An early line-up in the International Track includes companies from Canada, Israel and Japan. Please check our website at www.midatlanticbio.org for updates.

About 2008 Mid-Atlantic Bio

Mid-Atlantic Bio is the only regional event to combine components of an industry convention and investor conference under one roof. Co-hosted by the Tech Council of Maryland/MdBio (TCM/MdBio), the Mid-Atlantic Venture Association (MAVA), and the Virginia Biotechnology Association (VaBIO), the initiative benefits from broad regional support, including the investor and greater business communities, academic institutions, government agencies, and partnered regional associations. The event aims to bring together a critical mass of public and private stakeholders, including biotechnology and pharmaceutical senior executives, scientists and researchers, academia, policy makers, legislators, and venture capitalists to provide a premiere mid-Atlantic networking and business development forum, leverage the region’s world-renowned R&D resources and opportunities, and favorably position the region’s biotechnology industry in terms of its collective strengths, resources and competencies among key constituencies.

About the Tech Council of Maryland/MdBio

The MdBio Division of Tech Council of Maryland seeks to support and advance the bioscience industry in Maryland and the region. The mission of the 150-member MdBio division is to create an environment where bioscience businesses can collaborate, grow and succeed. For more information, please visit www.techcouncilmd.com.

About Mid-Atlantic Venture Association

Founded in 1986, MAVA represents the collective interests of private equity and venture capitalists investing in the mid-Atlantic, including more than 500+ venture professionals, at 125 firms, with more than $100 billion in capital under management. For more information, please visit www.mava.org.

About Virginia Biotechnology Association

Virginia Biotechnology Association (VaBIO) is the 150-member statewide trade group that promotes the considerable scientific and economic impact of the life sciences industry in the Commonwealth of Virginia. For more information, please visit www.vabio.org.